05/06/2024
7:03 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
7:06 AM | Lyell Immunopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
7:12 AM | Lyell Immunopharma (Filer)
| Form 424B5 | |
05/05/2024
11:15 PM | Lyell Immunopharma (Filer)
| Form EFFECT | |
04/22/2024
3:15 PM | Lyell Immunopharma (Filer)
| Form DEF 14A | |
04/22/2024
3:16 PM | Lyell Immunopharma (Filer)
| Form DEFA14A | |
04/22/2024
3:17 PM | Lyell Immunopharma (Filer)
| Form ARS | |
|
02/14/2024
2:18 PM | ARCH Venture Fund IX, L.P. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G/A | |
02/13/2024
7:22 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:24 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:25 PM | Lang Matthew (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:17 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:19 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G | |
11/20/2023
7:53 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:54 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:55 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:52 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:26 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:14 PM | Lyell Immunopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/11/2023
8:16 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
3:20 PM | Bishop Hans Edgar (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:22 PM | BRAWLEY OTIS W (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:23 PM | Lyell Immunopharma (Issuer)
NABEL ELIZABETH G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:24 PM | Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:26 PM | FRIEDMAN CATHY (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:27 PM | Lyell Immunopharma (Issuer)
RIEFLIN WILLIAM JL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
3:23 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
2:04 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
2:08 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
2:16 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
2:19 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/20/2023
12:07 PM | Lang Matthew (Reporting)
Lyell Immunopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2023
4:42 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
4:47 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
4:32 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
4:36 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
3:47 PM | Lyell Immunopharma (Issuer)
NABEL ELIZABETH G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:49 PM | Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:51 PM | Lyell Immunopharma (Issuer)
RIEFLIN WILLIAM JL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:40 PM | Bishop Hans Edgar (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Incredible Opportunity to Retire FAST! (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |
06/20/2023
3:41 PM | BRAWLEY OTIS W (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:43 PM | FRIEDMAN CATHY (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:45 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
